These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 9865378)

  • 1. Effect of low-molecular-weight heparin on development of cardiac allograft vascular disease following heart transplantation in rats.
    Hisatomi K
    Transplant Proc; 1998 Dec; 30(8):4337-9. PubMed ID: 9865378
    [No Abstract]   [Full Text] [Related]  

  • 2. A reduction in accelerated graft coronary disease and an improvement in cardiac allograft survival using low molecular weight heparin in combination with cyclosporine.
    Aziz S; Tada Y; Gordon D; McDonald TO; Fareed J; Verrier ED
    J Heart Lung Transplant; 1993; 12(4):634-43. PubMed ID: 8396435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of rapamycin, RS 61443, cyclosporine, and low-dose heparin as treatment for transplant vasculopathy in a rat model of chronic allograft rejection.
    Schmid C; Heemann U; Azuma H; Tilney NL
    Transplant Proc; 1995 Feb; 27(1):438-9. PubMed ID: 7879053
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of hyperlipidemia and immunosuppressive drugs on cardiac allograft vascular disease in heterotopic rat cardiac transplantation.
    Hisatomi K; Isomura T; Matsuzoe S; Satou T; Hirano A; Kohjiro M
    Transplant Proc; 1996 Jun; 28(3):1958-60. PubMed ID: 8658960
    [No Abstract]   [Full Text] [Related]  

  • 5. Induction therapy with an immunomodulatory CD2 antibody does not inhibit allograft vasculopathy after rat heart transplantation.
    Dengler TJ; Szabo G; Amann K; Nottmeyer W; Vahl C; Hagl S; Zimmermann R
    Transplant Proc; 1998 May; 30(3):868-70. PubMed ID: 9595130
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of cyclosporine on chronic graft vascular disease in a rat cardiac isograft model.
    Teranishi K; Poston RS; Tsao PS; Asagami T; Cooke JP; Reitz BA; Robbins RC
    Transplant Proc; 1998 Jun; 30(4):1012-3. PubMed ID: 9636409
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of low molecular weight heparin on graft vascular disease in the rat cardiac allograft model.
    Teranishi K; Poston RS; Reitz BA; Robbins RC
    Transplant Proc; 1999; 31(1-2):103-5. PubMed ID: 10083030
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of low molecular weight heparin on suppression of chronic graft vascular disease in a rat cardiac allograft model.
    Teranishi K; Poston RS; Reitz BA; Robbins RC
    Transplant Proc; 1998 Jun; 30(4):1009-11. PubMed ID: 9636408
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of dose of cyclosporine or FK506 and antithrombotic agents on cardiac allograft vascular disease in heterotopically transplanted hearts in rats.
    Hisatomi K; Isomura T; Ohashi M; Tamehiro K; Sato T; Tayama E; Ohishi K; Kohjiro M
    J Heart Lung Transplant; 1995; 14(1 Pt 1):113-8. PubMed ID: 7537098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control and reversal of chronic xenograft rejection in hamster-to-rat cardiac transplantation.
    Xiao F; Shen J; Chong A; Liu W; Foster P; Blinder HL; Sankary H; McChesney L; Mital D; Williams JW
    Transplant Proc; 1996 Apr; 28(2):691-2. PubMed ID: 8623348
    [No Abstract]   [Full Text] [Related]  

  • 11. Oral delivery of low molecular weight heparin in rat cardiac allografts.
    Teranishi K; Poston RS; Reitz BA; Robbins RC
    Transplant Proc; 1998 Jun; 30(4):996-7. PubMed ID: 9636402
    [No Abstract]   [Full Text] [Related]  

  • 12. Antisense ICAM-1 oligonucleotides block allograft rejection in rats.
    Stepkowski SM; Wang ME; Amante A; Kalinin D; Qu X; Blasdel T; Condon T; Kahan BD; Bennett FC
    Transplant Proc; 1997; 29(1-2):1285. PubMed ID: 9123308
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibitory effect of 15-deoxyspergualin on coronary arteriosclerosis in the transplanted heart.
    Hachida M; Zhang X; Lu H; Hoshi H; Koyanagi H
    Transplant Proc; 1999; 31(1-2):143-6. PubMed ID: 10083050
    [No Abstract]   [Full Text] [Related]  

  • 14. Dose- and time-related acceleration of chronic graft vascular disease caused by cyclosporine in a rat cardiac isograft model.
    Teranishi K; Usui A; Maseki T; Watanabe T; Yasuura K; Imaizumi M
    Transplant Proc; 1999 Nov; 31(7):2801-3. PubMed ID: 10578298
    [No Abstract]   [Full Text] [Related]  

  • 15. Allochimeric class I MHC inhibits chronic rejection in cardiac allografts.
    Singer JS; Shen X; Fishbein M; Mhoyan A; Zhao D; Reemsteen B; Gao F; Amersi F; Coito AJ; Busuttil RW; Weglinski JK; Ghobrial RM
    Transplant Proc; 2001; 33(1-2):179. PubMed ID: 11266768
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibition of transplant vasculopathy is associated with attenuated host allo-antibody response.
    Maggard MA; Johnson C; Wang T; Terasaki P; Kupiec-Weglinski JW; Busuttil RW; Imagawa DK
    Transplant Proc; 1999; 31(1-2):728-9. PubMed ID: 10083311
    [No Abstract]   [Full Text] [Related]  

  • 17. The influence of antigen-dependent and antigen-independent factors on the development of graft vasculopathy in a fully allogeneic cardiac allograft model in the rat.
    Fiedel S; Bayer J; Schaub M; Heidt MC; Grebe M; Tillmanns H; Stadlbauer TH
    Transplant Proc; 2009; 41(6):2625-7. PubMed ID: 19715988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of chronic renal allograft rejection in rats with a low-molecular-weight heparin (reviparin).
    Braun C; Schultz M; Fang L; Schaub M; Back WE; Herr D; Laux V; Rohmeiss P; Schnuelle P; van der Woude FJ
    Transplantation; 2001 Jul; 72(2):209-15. PubMed ID: 11477340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TCV-116 reduces chronic rejection in a rat heterotopic cardiac transplant model.
    Richter M; Westphal M; Maybaum B; Richter H; Skupin M; Mohr FW; Olbrich HG
    Transplant Proc; 1999; 31(1-2):106-7. PubMed ID: 10083031
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of a new immunosuppressive drug, brequinar sodium, on heart, liver, and kidney allograft rejection in the rat.
    Cramer DV; Chapman FA; Jaffee BD; Jones EA; Knoop M; Hreha-Eiras G; Makowka L
    Transplantation; 1992 Feb; 53(2):303-8. PubMed ID: 1531394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.